Cargando…
Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer
BACKGROUND: Non-small-cell lung cancer (NSCLC) represents the most frequent subtype of lung cancer. MicroRNAs (miRNAs) have attracted a lot of attention with regard to their clinical significance and crucial biological functions in various human cancers. This study aimed to investigate the prognosti...
Autores principales: | Li, Yunxia, Cui, Xiaomei, Li, Yongdeng, Zhang, Tingting, Li, Shuyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095112/ https://www.ncbi.nlm.nih.gov/pubmed/30147363 http://dx.doi.org/10.2147/CMAR.S167432 |
Ejemplares similares
-
Upregulation of miR-421 predicts poor prognosis and promotes proliferation, migration, and invasion of papillary thyroid cancer cells
por: Dong, Anbing, et al.
Publicado: (2020) -
Upregulation of Serum miR-629 Predicts Poor Prognosis for Non-Small-Cell Lung Cancer
por: Liu, Fayong, et al.
Publicado: (2021) -
circ_0000567/miR-421/TMEM100 Axis Promotes the Migration and Invasion of Lung Adenocarcinoma and Is Associated with Prognosis
por: Hong, Yang, et al.
Publicado: (2022) -
Serum exosomal miR‐378 upregulation is associated with poor prognosis in non–small‐cell lung cancer patients
por: Zhang, Yan, et al.
Publicado: (2020) -
Circ_MACF1 targets miR‐421 to upregulate FMO2 to suppress paclitaxel resistance and malignant cellular behaviors in lung adenocarcinoma
por: Qian, Xiaoting, et al.
Publicado: (2023)